Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study

Thomas Jefferson University

Status

Active, not recruiting

Conditions

Prostate Carcinoma

Treatments

Other: Survey Administration

Other: Educational Intervention

Other: Interview

Study type

Observational

Funder types

Other

Identifiers

NCT04789018

JT 16041 (Other Identifier)

20F.936

080-27000-X17501 (Other Grant/Funding Number)

Details and patient eligibility

About

This study assesses perceived usefulness of a web-based virtual prostate cancer genetics board for providers across academic, community, and veteran affairs settings to discuss prostate cancer genetics cases, precision treatment, and screening recommendation. Information gained from interviews and surveys of participants taking part in the virtual genetics board may lend insights into perceived usefulness, perceived ease of use, acceptability, self-efficacy, genetics knowledge, and barriers/facilitators to implementation to refine the process.

Full description

PRIMARY OBJECTIVE:

I. To assess perceived usefulness of a virtual genetics board.

SECONDARY OBJECTIVE:

I. To assess acceptability/feasibility, perceived ease of use, self-efficacy for recommendations, genetics knowledge.

OUTLINE:

Participants complete a survey about genetic knowledge and self efficacy and then attend virtual genetics board. After virtual genetics board meeting, participants complete a second survey about perceived usefulness, ease of use, acceptability, feasibility, self-efficacy and genetic knowledge. Participants may also complete a semi-structured interview after virtual genetics board.

Enrollment

118 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Individuals must meet one of the following inclusion criteria in order to be eligible to participate in the study:

Healthcare providers (medical oncologists, radiation oncologists, urologists, primary care providers, mid-level providers) who evaluate, manage, or treat men with prostate cancer or screen men for prostate cancer.
Providers who perform prostate cancer genetic testing for men (genetic counselors or healthcare providers)
Scientists and researchers
Advocacy or patient stakeholder organization members

Exclusion criteria

• Non-medical providers